Dr. Ahmad Zarzour

Claim this profile

University of Toledo

Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
3 reported clinical trials
11 drugs studied

Area of expertise

1

Lung Cancer

Ahmad Zarzour has run 2 trials for Lung Cancer. Some of their research focus areas include:

Stage III
Stage II
Stage I
2

Non-Small Cell Lung Cancer

Ahmad Zarzour has run 2 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:

Stage III
Stage II
Stage I

Affiliated Hospitals

Image of trial facility.

University Of Toledo

Clinical Trials Ahmad Zarzour is currently running

Image of trial facility.

Immunotherapy + Chemotherapy

for Non-Small Cell Lung Cancer

This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.

Recruiting

2 awards

Phase 3

27 criteria

Image of trial facility.

Perioperative Chemotherapy

for Pancreatic Cancer

This phase III trial compares perioperative chemotherapy (given before and after surgery) versus adjuvant chemotherapy (given after surgery) for the treatment of pancreatic cancer that can be removed by surgery (removable/resectable). Chemotherapy drugs, such as fluorouracil, irinotecan, leucovorin, and oxaliplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving chemotherapy before and after surgery (perioperatively) may work better in treating patients with pancreatic cancer compared to giving chemotherapy after surgery (adjuvantly).

Recruiting

4 awards

Phase 3

18 criteria

More about Ahmad Zarzour

Clinical Trial Related

11 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical Trials

Treatments Ahmad Zarzour has experience with

  • Biospecimen Collection
  • Carboplatin
  • Gemcitabine Hydrochloride
  • Paclitaxel
  • Pembrolizumab
  • Pemetrexed Disodium

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Ahmad Zarzour specialize in?

Is Ahmad Zarzour currently recruiting for clinical trials?

Are there any treatments that Ahmad Zarzour has studied deeply?

What is the best way to schedule an appointment with Ahmad Zarzour?

What is the office address of Ahmad Zarzour?

Is there any support for travel costs?